Replimune (REPL) Non-Current Assets (2018 - 2025)

Replimune's (REPL) quarterly Non-Current Assets came in at $53.2 million in Q4 2025, down 5.02% year-on-year from $56.1 million in Q4 2024, and down 4.43% quarter-over-quarter from $55.7 million in Q3 2025.

Replimune (REPL) Non-Current Assets (2018 - 2025) Analysis & Trends

Replimune has disclosed Non-Current Assets across 8 years of filings, most recently posting $53.2 million for Q4 2025.

  • Non-Current Assets for Q4 2025 came in at $53.2 million, down 5.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $220.5 million (changed 0.09% YoY), and the FY2025 annual result was $55.4 million, up 2.58% from the prior year.
  • Non-Current Assets came in at $53.2 million for Q4 2025 at Replimune, down from $55.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $59.4 million in Q1 2021 to a low of $53.2 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $55.6 million (2024), against an average of $55.9 million.
  • Across the five-year window, Non-Current Assets decreased 6.32% in 2023 and rose 4.25% in 2024, its largest moves.
  • Replimune's Non-Current Assets stood at $57.5 million in 2021, then slipped by 5.04% to $54.6 million in 2022, then declined by 1.51% to $53.8 million in 2023, then increased by 4.25% to $56.1 million in 2024, then fell by 5.02% to $53.2 million in 2025.
  • The last three Non-Current Assets figures came in at $53.2 million (Q4 2025), $55.7 million (Q3 2025), and $56.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 62,953.78
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4.56 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 30.30 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.71 Bn 91.71 Bn - 39.71 Mn
10 Replimune 780.01 Mn 510.88 Mn - 53.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 53.24 Mn
Sep 30, 2025 55.70 Mn
Jun 30, 2025 56.14 Mn
Mar 31, 2025 55.45 Mn
Dec 31, 2024 56.05 Mn
Sep 30, 2024 55.57 Mn
Jun 30, 2024 54.65 Mn
Mar 31, 2024 54.06 Mn
Dec 31, 2023 53.77 Mn
Sep 30, 2023 54.22 Mn
Jun 30, 2023 53.85 Mn
Mar 31, 2023 53.99 Mn
Dec 31, 2022 54.59 Mn
Sep 30, 2022 56.71 Mn
Jun 30, 2022 57.48 Mn
Mar 31, 2022 57.22 Mn
Dec 31, 2021 57.49 Mn
Sep 30, 2021 59.08 Mn
Jun 30, 2021 59.16 Mn
Mar 31, 2021 59.35 Mn